Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Camilla Labrie

2PUBLICATIONS

17CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jan 09, 2024

Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.

Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen

|Mar 02, 2023

Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy.

Christianne Groeneveldt, Jurriaan Q van Ginkel, Priscilla Kinderman

Pageof 1

Frequent Collaborators

2 joint publications

Christianne Groeneveldt

2 joint publications

Priscilla Kinderman

2 joint publications

Lisa Griffioen

2 joint publications

Diana J M van den Wollenberg

2 joint publications

Rob C Hoeben

2 joint publications

Sjoerd H van der Burg

2 joint publications

Nadine van Montfoort

2 joint publications

Thorbald van Hall

1 joint publications

Jurriaan Q van Ginkel

1 joint publications

Marjolein Sluijter

Frequent Collaborators

2 joint publications

Christianne Groeneveldt

2 joint publications

Priscilla Kinderman

2 joint publications

Lisa Griffioen

2 joint publications

Diana J M van den Wollenberg

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

See more related videos

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

See more related videos